Effects of congenital heart disease on fetal and neonatal circulations.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000818:Animals; D000831:Animals, Newborn; D001017:Aortic Coarctation / Q000503:physiopathology; D001285:Atropine / Q000494:pharmacology; D001775:Blood Circulation; D001794:Blood Pressure; D001920:Bradykinin / Q000378:metabolism; D002302:Cardiac Output; D002319:Cardiovascular System / Q000503:physiopathology; D003326:Coronary Circulation; D004373:Ductus Arteriosus / Q000503:physiopathology; D005318:Fetal Heart / Q000033:anatomy & histology / Q000502:physiology / Q000503:physiopathology*; D005865:Gestational Age; D006330:Heart Defects, Congenital / Q000503:physiopathology*; D006439:Hemodynamics; D006801:Humans; D007231:Infant, Newborn; D010101:Oxygen Consumption; D011651:Pulmonary Artery / Q000503:physiopathology; D011652:Pulmonary Circulation; D012039:Regional Blood Flow; D012756:Sheep; D014655:Vascular Resistance
D001285:Atropine; D000109:Acetylcholine; D001920:Bradykinin